Localized and diffuse tenosynovial giant cell tumor: real-world results from a patient observational registry
Greater awareness of TGCT among HCPs is needed to facilitate diagnosis and referral to multidisciplinary teams is warranted to reduce recurrence rates, number of surgical interventions, and improve QoL.
Authors
- Sean O’Neill (ORCID: https://orcid.org/0000-0002-6739-832X)
- Nicholas Matthew Bernthal (ORCID: https://orcid.org/0000-0003-3338-5878)
- Sara Rothschild (ORCID: https://orcid.org/0000-0001-6602-3924)
- Sydney Stern (ORCID: https://orcid.org/0000-0002-1479-605X)
- William D. Tap (ORCID: https://orcid.org/0000-0001-7779-2796)
- R. Lor Randall (ORCID: https://orcid.org/0000-0002-3660-774X)
- Thomas J. Scharschmidt (ORCID: https://orcid.org/0000-0002-5249-663X)
- Emanuela Palmerini (ORCID: https://orcid.org/0000-0003-3406-6705)
- Patrick F. McKenzie
Institutions
- Nationwide Children's Hospital (US)
- Memorial Sloan Kettering Cancer Center (US)
- Queen's University (CA)
- Cornell University (US)
- Harvard University Press (US)
- Life Raft Group (US)
- University of California, Davis (US)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1080/14796694.2025.2488635
- Citations
- 3
- Primary Topic
- Musculoskeletal synovial abnormalities and treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.00